109 related articles for article (PubMed ID: 33508120)
1. CSN5 Promotes Carcinogenesis of Thyroid Carcinoma Cells Through ANGPTL2.
Xie P; Wang H; Fang J; Du D; Tian Z; Zhen J; Liu Y; Ding Y; Fu B; Liu F; Huang D; Yu J
Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33508120
[TBL] [Abstract][Full Text] [Related]
2. CSN5 controls the growth of osteosarcoma via modulating the EGFR/PI3K/Akt axis.
Wan Z; Huang S; Mo F; Yao Y; Liu G; Han Z; Chen M; Zhiyun L
Exp Cell Res; 2019 Nov; 384(2):111646. PubMed ID: 31560888
[TBL] [Abstract][Full Text] [Related]
3. CSN5/Jab1 facilitates non-small cell lung cancer cell growth through stabilizing survivin.
Li J; Li Y; Wang B; Ma Y; Chen P
Biochem Biophys Res Commun; 2018 Jun; 500(2):132-138. PubMed ID: 29596838
[TBL] [Abstract][Full Text] [Related]
4. CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.
Liu H; Hu J; Pan H; Luo D; Huang M; Xu W
Dig Dis Sci; 2018 Jan; 63(1):155-165. PubMed ID: 29189991
[TBL] [Abstract][Full Text] [Related]
5. α5-nAChR contributes to epithelial-mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer.
Chen X; Jia Y; Zhang Y; Zhou D; Sun H; Ma X
J Cell Mol Med; 2020 Feb; 24(4):2497-2506. PubMed ID: 31930655
[TBL] [Abstract][Full Text] [Related]
6. CSN5 promotes the invasion and metastasis of pancreatic cancer by stabilization of FOXM1.
Mao L; Le S; Jin X; Liu G; Chen J; Hu J
Exp Cell Res; 2019 Jan; 374(2):274-281. PubMed ID: 30352219
[TBL] [Abstract][Full Text] [Related]
7. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein.
Huang M; Xiong H; Luo D; Xu B; Liu H
Exp Cell Res; 2020 Mar; 388(2):111876. PubMed ID: 31991125
[TBL] [Abstract][Full Text] [Related]
8. CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression.
Adler AS; Littlepage LE; Lin M; Kawahara TL; Wong DJ; Werb Z; Chang HY
Cancer Res; 2008 Jan; 68(2):506-15. PubMed ID: 18199546
[TBL] [Abstract][Full Text] [Related]
9. PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of β-catenin and PD-L1.
Ma Y; Xia P; Wang Z; Xu J; Zhang L; Jiang Y
Neoplasia; 2021 Sep; 23(9):912-928. PubMed ID: 34325342
[TBL] [Abstract][Full Text] [Related]
10. Roles for CSN5 in control of p53/MDM2 activities.
Zhang XC; Chen J; Su CH; Yang HY; Lee MH
J Cell Biochem; 2008 Mar; 103(4):1219-30. PubMed ID: 17879958
[TBL] [Abstract][Full Text] [Related]
11. CSN5 promotes renal cell carcinoma metastasis and EMT by inhibiting ZEB1 degradation.
Zhang S; Hong Z; Chai Y; Liu Z; Du Y; Li Q; Liu Q
Biochem Biophys Res Commun; 2017 Jun; 488(1):101-108. PubMed ID: 28479251
[TBL] [Abstract][Full Text] [Related]
12. Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.
Pan Y; Wang S; Su B; Zhou F; Zhang R; Xu T; Zhang R; Leventaki V; Drakos E; Liu W; Claret FX
Oncogene; 2017 Feb; 36(8):1069-1079. PubMed ID: 27524414
[TBL] [Abstract][Full Text] [Related]
13. The putative oncotarget CSN5 controls a transcription-uncorrelated p53-mediated autophagy implicated in cancer cell survival under curcumin treatment.
Zhang QY; Jin R; Zhang X; Sheng JP; Yu F; Tan RX; Pan Y; Huang JJ; Kong LD
Oncotarget; 2016 Oct; 7(43):69688-69702. PubMed ID: 27626169
[TBL] [Abstract][Full Text] [Related]
14. The emerging roles of Jab1/CSN5 in cancer.
Wang L; Zheng JN; Pei DS
Med Oncol; 2016 Aug; 33(8):90. PubMed ID: 27412572
[TBL] [Abstract][Full Text] [Related]
15. The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells.
Wang Y; Sun Q; Mu N; Sun X; Wang Y; Fan S; Su L; Liu X
Cell Commun Signal; 2020 Jul; 18(1):112. PubMed ID: 32665011
[TBL] [Abstract][Full Text] [Related]
16. The pivotal oncogenic role of Jab1/CSN5 and its therapeutic implications in human cancer.
Guo Z; Wang Y; Zhao Y; Shu Y; Liu Z; Zhou H; Wang H; Zhang W
Gene; 2019 Mar; 687():219-227. PubMed ID: 30468907
[TBL] [Abstract][Full Text] [Related]
17. The COP9 signalosome stabilized MALT1 promotes Non-Small Cell Lung Cancer progression through activation of NF-κB pathway.
Wang Y; Deng X; Xie J; Lu T; Qian R; Guo Z; Zeng X; Liao J; Ding Z; Zhou M; Niu X
Cell Biol Toxicol; 2024 Jun; 40(1):45. PubMed ID: 38864940
[TBL] [Abstract][Full Text] [Related]
18. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.
Tomoda K; Kubota Y; Arata Y; Mori S; Maeda M; Tanaka T; Yoshida M; Yoneda-Kato N; Kato JY
J Biol Chem; 2002 Jan; 277(3):2302-10. PubMed ID: 11704659
[TBL] [Abstract][Full Text] [Related]
19. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
Wang S; Pan Y; Zhang R; Xu T; Wu W; Zhang R; Wang C; Huang H; Calin CA; Yang H; Claret FX
Oncogene; 2016 Nov; 35(47):6096-6108. PubMed ID: 27157611
[TBL] [Abstract][Full Text] [Related]
20. COP9 subunits 4 and 5 target soluble guanylyl cyclase α1 and p53 in prostate cancer cells.
Bhansali M; Shemshedini L
Mol Endocrinol; 2014 Jun; 28(6):834-45. PubMed ID: 24725084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]